Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01461070 · ClinicalTrials.gov registry record
Intestine Bacteria and Breast Cancer Risk
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 175
- Enrollment target
NCT01461070: Completed study, sponsored by National Cancer Institute (NCI).
NCT01461070 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 175 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01461070 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 175 participants
- Enrollment target
Study Summary
Background: \- Some bacteria found in the large and small intestines help keep people healthy and aid digestion. They may also affect a person s risk of developing cancer. Researchers want to study the relationship between intestinal bacteria and breast cancer risk factors. They can do this by looking at stool and urine samples from postmenopausal women. Objectives: \- To study intestinal bacteria and its relationship to urine-based markers of breast cancer risk in women. Eligibility: \- Women between 55 and 69 years of age with a recent mammogram that showed no signs of cancer. Design: * Participants will be screened with a medical history and basic health questionnaire. * At home, participants will complete questionnaires about cancer risk factors and food consumption. * Participants will also collect urine and stool samples. They will send the samples to the designated labs for study. * No treatment will be provided as part of this protocol.
Primary Outcome
breast cancer association
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2011-08-10 |
| Est. Completion | 2020-05-22 |
What the finished NCT01461070 record still lists
NCT01461070 is an observational study that tracks outcomes without assigning an intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01461070 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01461070 about?
NCT01461070 is a clinical study titled "Intestine Bacteria and Breast Cancer Risk". Background: \- Some bacteria found in the large and small intestines help keep people healthy and aid digestion. They may also affect a person s risk of developing cancer. Researchers want to study the relationship between intestinal bacteria and breast cancer risk factors. They can do this by look...
What is the current status of trial NCT01461070?
This trial is currently completed. The enrollment target is 175 participants. The study started on 2011-08-10. Estimated completion is 2020-05-22.
Who is sponsoring clinical trial NCT01461070?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI